Mabpharm Limited's total assets for Q4 2024 were ¥1.02B, an increase of 7.38% from the previous quarter. HK:2181 total liabilities were ¥927.28M for the fiscal quarter, a 11.56% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.